Antigen News and Research

RSS

Covid-19 vaccine-elicited immune cells persist six months after vaccination, study shows

A recent study by Johns Hopkins Medicine researchers provides evidence that CD4+ T lymphocytes — immune system cells also known as helper T cells — produced by people who received either of the two available messenger RNA (mRNA) vaccines for COVID-19 persist six months after vaccination at only slightly reduced levels from two weeks after vaccination and are at significantly higher levels than for those who are unvaccinated.

17 Nov 2021

New technique anticipated to deliver personalized immunotherapies for cancer

Recent research led to a very effective technique to create many immune cells particularly engineered to identify neoantigens.

17 Nov 2021

Researchers test a neoantigen-specific transgenic immune cell therapy for malignant gliomas

Doctors and scientists from the German Cancer Research Center (DKFZ) and from Heidelberg University's Medical Faculty Mannheim have successfully tested a neoantigen-specific transgenic immune cell therapy for malignant brain tumors for the first time using an experimental model in mice.

16 Nov 2021

CRISPR screening identifies metabolic enzyme as new target for anti-inflammatory therapeutics

A metabolic enzyme that has been studied in cancer biology and is important for T cell function may offer a new target for anti-inflammatory therapeutics, Vanderbilt researchers have discovered.

12 Nov 2021

Avoiding the formation of false positive results during SARS-CoV-2 antigen testing

In light of frequent false positives, a team of Canadian researchers has shown that rapid antigen tests for SARS-CoV-2 work only when manufacturer instructions are followed.

11 Nov 2021

Transformative technology aims to provide insights into the function of immune cells

Immunotherapy has revolutionized cancer treatment and it is not an overstatement.

8 Nov 2021

Novel genetic biomarkers accurately predict SARS-CoV-2 infection, says study

Researchers from the University of Colorado School of Medicine identified specific genetic biomarkers that reveal who is infected with COVID-19.

29 Oct 2021

Horse hyperimmune antibody may be an efficient approach to combat SARS-CoV-2

A study conducted by a consortium of Brazilian researchers has demonstrated that a hyperimmune serum consisting of purified antibody fragments produced in horses may be an efficient approach to combat covid-19.

27 Oct 2021

Researchers develop chimeric exosomes that co-activate immune response and tumor microenvironment

Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences have developed macrophage–tumor chimeric exosomes that co-activate the immune response and tumor microenvironment to support cancer immunotherapy.

18 Oct 2021

Creating Protein Songs Using Classical Music

AZoLifeSciences speaks to researchers about their latest protein research, and how protein songs can be created from classical music.

From National University of Singapore (NUS) 7 Oct 2021

New gel enhances immunotherapy's effectiveness in glioblastoma

Pairing a newly developed gel with immunotherapy that was delivered to post-surgical mouse brains with glioblastoma, a highly malignant and deadly cancer, improved the immunotherapy's effectiveness, report researchers from the University of North Carolina Lineberger Comprehensive Cancer Center and colleagues.

7 Oct 2021

Clinical efficacy of CAR-T cells depends on chemical modifications, says study

One in five cancers affects lymph nodes and blood cells resulting in lymphomas and leukemias, respectively.

7 Oct 2021

New study reveals lung cell roles in guiding the immune system

Lung immunity is essential to combat all pulmonary diseases, including COVID-19, pneumonia, lung cancer, asthma and COPD.

6 Oct 2021

Novel Assay Platform for 3D Microfluidic Cancer Research

AMSBIO have supplied custom Chimeric antigen receptor (CAR)-T products to the University of Strathclyde (UoS) in Glasgow, UK, and ScreenIn3D Ltd, allowing them to perform novel immune-oncology assays in 3D microfluidic cancer models.

From AMS Biotechnology 1 Oct 2021

Researchers develop a DNA sensor to target and detect infectious viruses in minutes

A new sensor can detect not only whether a virus is present, but whether it's infectious – an important distinction for containing viral spread.

23 Sep 2021

Vaccinating against certain cancer proteins can boost overall immune response and shrink tumors

Over the past decade, scientists have been exploring vaccination as a way to help fight cancer. These experimental cancer vaccines are designed to stimulate the body's own immune system to destroy a tumor, by injecting fragments of cancer proteins found on the tumor.

17 Sep 2021

Antigen News and Research

Covid-19 vaccine-elicited immune cells persist six months after vaccination, study shows

New technique anticipated to deliver personalized immunotherapies for cancer

Researchers test a neoantigen-specific transgenic immune cell therapy for malignant gliomas

CRISPR screening identifies metabolic enzyme as new target for anti-inflammatory therapeutics

Avoiding the formation of false positive results during SARS-CoV-2 antigen testing

Transformative technology aims to provide insights into the function of immune cells

Novel genetic biomarkers accurately predict SARS-CoV-2 infection, says study

Horse hyperimmune antibody may be an efficient approach to combat SARS-CoV-2

Researchers develop chimeric exosomes that co-activate immune response and tumor microenvironment

Creating Protein Songs Using Classical Music

New gel enhances immunotherapy's effectiveness in glioblastoma

Clinical efficacy of CAR-T cells depends on chemical modifications, says study

New study reveals lung cell roles in guiding the immune system

Novel Assay Platform for 3D Microfluidic Cancer Research

Researchers develop a DNA sensor to target and detect infectious viruses in minutes

Vaccinating against certain cancer proteins can boost overall immune response and shrink tumors

Study unravels novel therapeutic option for the treatment of psoriasis

Research identifies an unnoticed site for priming of CD8+ T cells—the spleen

Loss of natural HIV control preceded by functional impairment of T cells

UAB researchers identify an unnoticed additional site for priming of "killer" T cells

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics